The following government grants in the FederalGrants.com database contain the term housing in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| Service Area Competition-Additional Areas: Lexington, KY and Worcester, MA |
93.224 |
HRSA-22-125 |
| Trafficking Victim Assistance Program |
93.598 |
HHS-2022-ACF-IOAS-OTIP-ZV-0150 |
| Informing global polio eradication efforts through innovative modeling approaches |
93.185 |
CDC-RFA-GH22-2272 |
| The CDC National Centers of Excellence in Youth Violence Prevention (YVPCs): Rigorous Evaluation of Prevention Strategies to Prevent and Reduce Community Rates of Youth Violence |
93.136 |
RFA-CE-22-012 |
| Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS) |
93.161 |
RFA-TS-22-001 |
| Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional) |
93.172 |
RFA-HG-22-001 |
| Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Scientific Leadership Center (UM2 Clinical Trial Optional) |
93.242, 93.279, 93.865 |
RFA-HD-23-020 |
| Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional) |
93.242, 93.279, 93.865 |
RFA-HD-23-021 |
| BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed) |
93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867 |
RFA-NS-22-011 |
| New Investigator Gateway Awards for Collaborative T1D Research (R03 Clinical Trial Not Allowed) |
93.847 |
RFA-DK-21-030 |
| Continuation or Revision of NIDCR Clinical Trial Implementation Cooperative Agreement (UH3 Clinical Trial Required) |
93.121 |
PAR-22-068 |
| APS-OAA-21-00001 Addendum USAID/Haiti |
98.001 |
72052122APS00002 |
| Stimulating Urology Interdisciplinary Team Opportunity Research (SUITOR) (R01 Clinical Trial Optional) |
93.847 |
PAS-22-074 |
| Department of Interior Bureau of Land Management Headquarters Recreation and Visitor Services |
15.225 |
L22AS00085 |
| Authority to Accept Unsolicited Proposals for Research Partnerships |
14.506 |
FR-6500-N-USP |
| Bureau of Land Management Oregon/Washington Invasive and Noxious Plant Management |
15.230 |
L22AS00111 |
| FY 22 National Urban and Community Forestry Grant Program |
10.675 |
USDA-FS-UCF-010-2022 |
| National Centers for Metabolic Phenotyping in Live Models of Obesity and Diabetes (MPMOD) (U2C - Clinical Trial Not Allowed) |
93.847 |
RFA-DK-21-027 |
| Cooperative Agreement for CESU-affiliated Partner with Piedmont-South Atlantic Coast Cooperative Ecosystem Studies Unit |
15.808 |
G22AS00107 |
| Fostering Research With Additional Resources and Development (FORWARD) Urology Centers (P20 Clinical Trial Not Allowed) |
93.847 |
RFA-DK-21-032 |
| High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2 Clinical Trial Optional) |
93.847 |
PAR-22-069 |
| Drug Discovery For Nervous System Disorders (R01 Clinical Trials Not Allowed) |
93.242, 93.273, 93.279, 93.866 |
PAR-22-031 |
| Coordinating Unit for the National Centers for Metabolic Phenotyping in Live Models of Obesity and Diabetes (MPMOD) (U24 - Clinical Trial Not Allowed) |
93.847 |
RFA-DK-21-035 |
| Bureau of Land Management Oregon/Washington Wildlife Resource Management Program Opportunity |
15.247 |
L22AS00106 |
| Resource Networks for Protein Polymorphisms in Alzheimers Disease and its Related Dementias (AD/ADRD) (U24 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-22-030 |
| Bureau of Land Management Oregon/Washington Forest and Woodlands Resource Management |
15.233 |
L22AS00100 |
| NIGMS National and Regional Resources (R24 - Clinical Trial Not Allowed) |
93.859 |
PAR-22-065 |
| Bureau of Land Management Oregon/Washington Recreation and Visitor Services |
15.225 |
L22AS00099 |
| Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) |
93.394 |
RFA-CA-22-002 |
| Analysis, Technology, Leadership, Administration and Science (ATLAS) Center (U24 Clinical Trial Not Allowed) |
93.847 |
RFA-DK-21-034 |
| Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) |
93.394 |
RFA-CA-22-001 |
| YouthBuild |
17.274 |
FOA-ETA-22-01 |
| BLM Oregon/Washington Threatened and Endangered Species |
15.246 |
L22AS00098 |
| Toward Translation of Nanotechnology Cancer Interventions (TTNCI) (R01 Clinical Trial Not Allowed) |
93.394 |
PAR-22-071 |
| Measures and Methods to Advance Research on Minority Health and Health Disparities-Related Constructs (R01 Clinical Trial Not Allowed) |
93.113, 93.121, 93.242, 93.307, 93.393, 93.395, 93.396 |
PAR-22-072 |
| Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional) |
93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.394, 93.395, 93.837, 93.838, 93.839, 93.840, 93.846, 93.853, 93.855, 93.865, 93.867 |
PAR-21-343 |
| Basic Neurodevelopmental Biology of Circuits and Behavior (R21 Clinical Trial Not Allowed) |
93.242 |
PAR-22-067 |
| NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional) |
93.233, 93.837, 93.838, 93.839, 93.840 |
RFA-HL-23-009 |
| TB Centers of Excellence for Training, Education and Medical Consultation (COE) |
93.947 |
CDC-RFA-PS23-2301 |
| Pre-application: Opportunities for Collaborative Research at the NIH Clinical Center (X02 Clinical Trial Optional) |
93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.394, 93.395, 93.837, 93.838, 93.839, 93.840, 93.846, 93.853, 93.855, 93.865, 93.867 |
PAR-21-342 |
Search Results 2641-2680 of 17636
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 [Next] |
